Mumbai, Nov. 10 -- Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 10 November 2025, has recommended a First Interim Dividend of Rs.0.50 per share (i.e.0.05), subject to the approval of the shareholders.

Published by HT Digital Content Services with permission from Capital Market....